Mount Sinai Medical Center Physician Leads Global Phase 3 Trial Showing Chemotherapy-Free Treatment Improves Outcomes for Women with dMMR Endometrial Cancer
KEYNOTE-C93/GOG-3064/ENGOT-en15 results presented in the ESMO 2026 Presidential Symposium and published simultaneously in The Lancet MIAMI BEACH, Fla., Oct. 26, 2026 /PRNewswire/ -- Women with advanced or recurrent mismatch repair deficient (dMMR) endometrial cancer who were treated with...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.